Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_502bfc0709ea9ed74ef0d69764f0be2c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-718 |
filingDate |
2013-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fc2bd7b85b2525f12d52875fe617c2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04b56f841265f57e5d7683c4f72ff8af |
publicationDate |
2019-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2698948-T3 |
titleOfInvention |
Hydroxyalkylated starch for the treatment of cancer by reducing the growth rates of tumors |
abstract |
A pharmaceutical composition comprising hydroxyethylated starch (HES), wherein HES is the only therapeutically active compound for use in the treatment of cancer, where the treatment is characterized by a reduction in the rate of tumor growth. |
priorityDate |
2012-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |